ioflupane: Clinical Trials

4 trials of ioflupane, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 withdrawn. 4 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 34Completed 3, Withdrawn 1

Follow ioflupane: new trials by email Literature Review of ioflupane trials Research Report on ioflupane

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients
DaTSCAN™ Ioflupane (123I) Injection - Parkinsonian Syndrome, Parkinson Disease(PD)
Phase 3CompletedGE Healthcare1722020-06-282023-10-16
A Cross-Over, Multi-Center Trial to Evaluate the Diagnostic Efficacy and Safety of [123I]NAV5001 as an Imaging Agent to Aid in the Diagnosis of Parkinsonian Syndromes
NAV5001, DaTscan - Parkinson's Syndrome
Phase 3WithdrawnNavidea Biopharmaceuticals2017-04-012017-09-13
Study of Dopamine and Serotonin Transporters in Patients With Amyotrophic Lateral Sclerosis and Controls
SPECT : 123 I-FP-CIT (DATSCAN) and 123I-ADAM - Amyotrophic Lateral Sclerosis
Phase 3CompletedAssistance Publique - Hôpitaux de Paris162012-10-012015-05-13
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
DatSCAN - Lewy Body Dementia, Non-DLB Dementia
Phase 3CompletedGE Healthcare3262003-11-012007-05-16

Conditions studied

Parkinson Disease (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Dementia, Vascular (1)  ·  Essential Tremor (1)  ·  Lewy Body Disease (1)  ·  Multiple System Atrophy (1)  ·  Parkinsonian Disorders (1)  ·  Supranuclear Palsy, Progressive (1)

Sponsors

GE Healthcare (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Navidea Biopharmaceuticals (1)

Countries

China (1)  ·  France (1)  ·  Germany (1)  ·  United States (1)

Top investigators

Cornelia Reininger, M.D. Ph.D. (1)  ·  Lucette Lacomblez, MD (1)  ·  Marc Pignot, PhD (1)

Results publications

PMID 24993764